Agomab Therapeutics NV: Agomab Expands Team with Reginald Brys as Head of Research and Maria Nichol as Head of IP
Agomab Therapeutics NV ('Agomab') today announced the expansion of its team with two key hires: Reginald Brys will join as Head of Research and Maria Nichol will become Head of Intellectual Property.
United Kingdom Onboarding Reginald Oxford Glycosciences Maria Nichol Reginald Brys Kostenloser Wertpapierhandel
Source: finanznachrichten.de